The FDA has provided a date of April 18, 2025, to review the application for Dupixent to treat patients with chronic ...

Put up against placebo in the phase 3 EMBARK trial, delandistrogene moxeparvovec (Elevidys) did not significantly improve ...

This story first appeared in The 19th. President-elect Donald Trump intends to nominate anti-vaccine conspiracy theorist ...

The FDA has approved the investigational new drug application of AS1986NS for prostate cancer detection and treatment.

Donald Trump's decision to nominate RFK to run HHS has some critics praising him and other critics shaking their heads in ...

Editorial writers dissect these public health topics.

In a conversation about the challenges and solutions for aging adults, Google's Gemini chatbot told a user: "You are a drain ...

President-elect Donald Trump's nomination of Robert F. Kennedy Jr. to lead the Department of Health and Human Services (HHS) ...

Adaptimmune’s Phase II IGNYTE-ESO trial investigating experimental T cell therapy lete-cel has achieved its primary endpoint.

"Johnson & Johnson MedTech announces partnership for soft tissue solutions" was originally created and published by Medical ...

A map shows places that Kennedy may tackle first due to high levels of obesity in those states, as reported by the Centers ...

Liquidia's collaboration on L606 boosts long-term growth potential. Find out why LQDA stock’s valuation and upcoming launches ...